Skip to main content

Agora
Sign in

House bill · H.R. 685 (119th Congress)

SAVE Moms and Babies Act of 2025

U.S. House of Representatives

Latest action Jun 3, 2026

Sponsor: Robert E. Latta (U.S. Representative, OH-5, Republican)

Follow

Following needs an Agora account. You will sign in first, then come back to this page.

From Congress.gov and official rosters. This record was last updated Jul 30, 2026. About our data

Summary

Support And Value Expectant Moms and Babies Act of 2025 or the SAVE Moms and Babies Act of 2025 This bill prohibits the Food and Drug Administration (FDA) from approving any new drug (either as a brand-name drug or a generic) intended to terminate a pregnancy and imposes additional restrictions on such drugs that are already approved. Under the bill, an already-approved drug intended to terminate a pregnancy may be dispensed to a patient only with a prescription. Furthermore, the FDA may not approve any labeling change that would authorize (1) using the drug after 70 days of gestation, or (2) dispensing the drug by any means other than in-person administration by the prescribing health care practitioner. The FDA must also impose additional restrictions on such already-approved drugs, including by (1) requiring the prescribing health care practitioner to receive a special certification, (2) prohibiting the practitioner from also acting as the dispensing pharmacist, and (3) requiring the practitioner to have the ability to provide surgical intervention to the patient. The bill also rescinds any investigational use exemption already granted to such a drug if the bill would have prohibited the FDA from granting the exemption. (Currently, the FDA may grant an exemption to certain market approval requirements if a drug is intended solely for use in safety and effectiveness investigations.)

Summary from the Congressional Research Service. How we handle summaries

Where it stands

Assigned to a committee for review.

  1. Introduced
  2. In committee
  3. Up for a vote
  4. Passed one chamber
  5. Passed
  6. Enacted

Committee

House Committee on Energy and Commerce · U.S. House of Representatives

Your position on this bill

Choose the position closest to yours. You'll sign in or create an account to save it.

Sign in or create an account to give your position

Cosponsors

63

Cosponsors listed on Congress.gov, shown A to Z.

  • Republican63

Shown in neutral colors by design; Agora is non-partisan.

Show the full list (63 names)

Related bills

As identified by Congress.gov.

Full history

  1. Jun 3, 2026

    Introduced

    Introduced in U.S. House

    U.S. House

  2. Jan 23, 2025

    Introduced

    Introduced in House

    U.S. House of Representatives

  3. Jan 23, 2025

    In committee

    Referred to the House Committee on Energy and Commerce.

    U.S. House

  4. Jan 23, 2025

    Referred to committee

    Referred to the House Committee on Energy and Commerce.

    U.S. House of Representatives

Read the record